OakChart

Pediatrix Medical Group Inc

MDHealthcare·Medical Care Facilities·USA·Mid·NYSE·Nov 11 • 12:56 PM ET

30.79-0.83 (-2.62%)
2026-11-11 18:57 CET
Market cap
2,470.30 USD m
Revenue, TTM
1,959.12 USD m
Net income, TTM
150.09 USD m
Free cash flow, TTM
209.59 USD m
EPS diluted, TTM
1.83
P/E
16.79
Compare

Price

MD against its 20, 50 and 200-day averages
2050200missearnings
20.0025.0030.001.1M2.1MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26MDclose 30.7920-day 29.7250-day 27.69200-day 24.2530.7952w high

8.7% under the 52-week high of 33.74 on 5 Nov 2026. 52-week low 17.23 on 19 Feb 2026. Last 15 sessions, 20.5% high to low

Profile

MD
52-week range, 82% of the way up
17.2333.74

Pediatrix Medical Group, Inc. engages in the provision of physician services. Its services include neonatal care, maternal fetal care, and other pediatric subspeciality care. The company was founded by Roger J. Medel in 1979 and is headquartered in Sunrise, FL.

IndexRUT
Employees6575
IPOSep 20, 1995
Beta0.60
ATR, 14d1.13
Rel volume0.81
Short float4.61%
Insider own1.59%
Inst own108.87%

Snapshot

6 groups

Valuation

IndexRUT
Market Cap2.41B
Enterprise Value2.59B
Income150.09M
Sales1.96B
Book/sh10.88
Cash/sh5.45
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout0.00%
Employees6575
IPOSep 20, 1995

Ratios

P/E16.79
Forward P/E12.24
PEG1.40
P/S1.23
P/B2.83
P/C5.65
P/FCF11.48
EV/EBITDA9.90
EV/Sales1.32
Quick Ratio1.28
Current Ratio1.28
Debt/Eq0.72
LT Debt/Eq0.50
Option/ShortYes / Yes

Earnings

EPS (ttm)1.83
EPS next Y2.52
EPS next Q0.63
EPS this Y18.56%
EPS next Y4.03%
EPS next 5Y8.71%
EPS past 3/5Y34.98% -
Sales past 3/5Y-0.99% 1.99%
EPS Y/Y TTM-1.56%
Sales Y/Y TTM1.91%
EPS Q/Q-29.63%
Sales Q/Q1.72%
EarningsOct 29 BMO
EPS/Sales Surpr.10.82% 0.64%

Ownership

Insider Own1.59%
Insider Trans-2.82%
Inst Own108.87%
Inst Trans-0.07%
ROA6.92%
ROE17.25%
ROIC11.81%
Gross Margin24.90%
Oper. Margin12.15%
Profit Margin7.66%
SMA203.60%
SMA5011.18%
SMA20026.95%
Trades-

Technical

Shs Outstand78.09M
Shs Float76.88M
Short Float4.61%
Short Ratio4.79
Short Interest3.55M
52W High33.74 -8.74%
52W Low17.23 78.70%
Volatility4.37% 3.63%
ATR (14)1.13
RSI (14)60.47
Beta0.60
Rel Volume0.81
Avg Volume740.75K
Volume333,069

Performance

Perf Week-6.13%
Perf Month15.71%
Perf Quarter16.76%
Perf Half Y28.40%
Perf YTD43.95%
Perf Year36.18%
Perf 3Y234.31%
Perf 5Y9.38%
Perf 10Y-49.98%
Recom3.00
Target Price30.08
Prev Close31.62
Price30.79
Change %-2.62%

Analyst ratings

latest 10 of 20
DateActionAnalystRating changeTargetImplied
TodayDowngradeMMizuhoNeutral → Underperform$28-9.1%
Aug 19, 2026DowngradeJJefferiesBuy → Hold$28-9.1%
Dec 16, 2024InitiatedMMacquarieOutperform
Sep 26, 2024UpgradeJJefferiesHold → Buy$8 → $14-54.5%
Jun 07, 2024UpgradeDDeutsche BankSell → Hold$8-74.0%
Sep 27, 2021InitiatedSSVB LeerinkMkt Perform$29-5.8%
Jun 23, 2021ResumedSStifelHold$30-2.6%
Oct 19, 2020DowngradeDDeutsche BankHold → Sell$20 → $12-61.0%
Jan 03, 2020DowngradeCCitigroupBuy → Neutral$29-5.8%
Dec 12, 2019UpgradeSStifelHold → Buy$25 → $33+7.2%

Peers

Mkt cap
TickerCompanyMkt cap
AVAHAveanna Healthcare Holdings Inc2.88B
AMNAMN Healthcare Services Inc1.47B
AGLAgilon Health Inc1.93B
ASTHAstrana Health Inc1.63B
HCAHCA Healthcare Inc104.44B
SGRYSurgery Partners Inc3.47B
ADUSAddus HomeCare Corp2.32B
USPHU.S. Physical Therapy Inc1.49B
PRVAPrivia Health Group Inc3.07B
RDNTRadnet Inc6.19B

Insider trading

10 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Mary Ann E MooreOfficerSep 11 '26Proposed Sale26.8421,335572,620Sep 14 06:14 PM
Mary Ann E MooreOfficerAug 14 '26Proposed Sale26.619,260246,366Sep 14 06:14 PM
Laura LinynskyDirectorSep 10 '26Proposed Sale26.796,000160,736Sep 10 04:28 PM
Sylvia YoungDirectorAug 14 '26Proposed Sale26.5918,500491,868Aug 14 05:43 PM
Weis Shirley ADirectorMay 13 '26Sale23.7536,028855,6650May 14 05:00 PM
Weis Shirley ADirectorMay 13 '26Proposed Sale23.6836,028853,143May 13 08:43 PM
ORDAN MARK SChief Executive OfficerDec 15 '25Sale22.4123,000515,430302,805Dec 17 05:00 PM
ORDAN MARK SDirectorDec 15 '25Proposed Sale22.5023,000517,500Dec 15 04:38 PM
Rucker Michael A.DirectorNov 17 '25Sale23.0010,478240,99459,101Nov 19 05:00 PM
Rucker Michael A.DirectorNov 17 '25Proposed Sale23.0010,478240,994Nov 17 06:35 PM

Held by

AUM
TickerCompanyAUM
IJRiShares Core S&P Small-Cap ETFAUM: 106.27B
IWMiShares Russell 2000 Index FundAUM: 77.38B
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VBVanguard Morningstar Small-Cap ETFAUM: 79.59B
DFATU.S. Targeted Value Portfolio-ETF Class Shares-
VBRVanguard Morningstar Small-Cap Value ETFAUM: 37.76B
DFSVUS Small Cap Value Portfolio ETF Class Shares-
IWNiShares Russell 2000 Value ETFAUM: 14.10B
VXFVanguard Extended Market Index ETFAUM: 30.47B
SPSMState Street SPDR Portfolio S&P 600TM Small Cap ETFAUM: 16.06B

News

latest 14 of 206
  • Pediatrix Beats And Lifts Its EBITDA Floor As Volumes Recover, But The Pricing Tailwind Has Run Out (Earnings Whispers)
  • Pediatrix Medical Group: Q3 Earnings Snapshot (Associated Press)
  • Pediatrix Medical Group Reports Third Quarter Results (Business Wire)
  • Pediatrix Rallies Into Q3 As Fading Pricing Tailwind Meets Softer Neonatal Volumes (Earnings Whispers)
  • Pediatrix Medical Group 2026 Third Quarter Conference Call/Webcast Scheduled for Thursday, October 29, 2026 (Business Wire)
  • Loading…
  • Pediatrix Medical Group Inc (MD) (Q2 2026) Earnings Call Highlights: Strong EBITDA and Payer ... (GuruFocus.com) -5.87% +5.18%
  • Pediatrix Medical Group: Q2 Earnings Snapshot (Associated Press)
  • Pediatrix Medical Group Reports Second Quarter Results (Business Wire)
  • Pediatrix Medical Group Provides Second Quarter Update (Business Wire) +7.34%
  • Universal Health Services Inc. Cl B stock outperforms competitors despite losses on the day (MarketWatch) -7.77%
  • Pediatrix Medical Group Announces Publication of New Research Addressing Urgent Questions in Neonatology (Business Wire)
  • Pediatrix Medical Group: Q1 Earnings Snapshot (Associated Press) -7.05%
  • Pediatrix Medical Group Reports First Quarter Results (Business Wire)

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
2026Q32026-10-290.7200.6500.590501.37498.187
2026Q22026-08-040.6300.5910.489487.78478.497
2026Q12026-05-050.4400.3800.356476.2465.837
2025Q42026-02-190.5000.5380.399493.77486.237
2025Q32025-11-030.6700.4650.838492.88476.447
2025Q22025-08-050.5300.4250.459468.84464.378
2025Q12025-05-060.3300.2420.243458.36451.448
2024Q42025-02-200.5100.3670.355502.36486.218
2024Q32024-11-010.4400.3680.230511.16498.877
2024Q22024-08-060.3400.313-1.836504.3505.498
2024Q12024-05-070.2000.1840.048495.1497.928
2023Q42024-02-200.3200.325-1.504496.44523.348
2023Q32023-11-020.3200.4350.258506.61507.596
2023Q22023-08-030.3900.4020.342501495.888
2023Q12023-05-020.2300.2290.173491.01490.758
2022Q42023-02-170.4700.4840.358513.84501.979

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
2018FY3.8203.8032.9323,6473,624
2019FY3.3803.370-17.9383,5143,509
2020FY0.9501.227-9.5511,7342,076
2021FY1.6301.5321.5261,9111,897
2022FY1.6601.6910.7891,9721,960
2023FY1.2601.249-0.7351,9952,022
2024FY1.5101.350-1.1892,0131,997
2025FY2.0402.0851.9401,9141,905
2026FY-2.419--1,970
2027FY-2.516--2,013
2028FY-2.621--2,069
2029FY-2.210--2,247

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
2026Q4S2026-11-10730504.22499.5518.06
2026Q4S2026-11-05730504.7499.5518.06
2026Q4S2026-11-01720503.86498.71518.06
2026Q4S2026-10-29730503.86498.71518.06
2026Q4S2026-10-27710499.14493.9506.1
2026Q4S2026-10-19710499.14493.9506.1
2026Q4S2026-10-18720499.14493.9506.1
2026Q4S2026-08-18740499.14493.9506.1
2026Q4S2026-08-13630499.44493.9506.1
2026Q4S2026-08-07730498.38491.98506.1
2026Q4S2026-08-05730498.21491.98506.1
2026Q4S2026-08-04720495.88491.98502.75
2026Q4S2026-07-19700494.01488.9500.07
2026Q4S2026-05-11701494.01488.9500.07

Estimate history

EPS, annual3.452.932-17.938-9.5511.5260.789-0.735-1.1891.941.8338
Period201720182019202020212022202320242025TTM
EPS, quarterly0.230.3550.2430.4590.8380.3990.3560.4890.589
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Sales, annual3458.3123454.811779.7591733.9511911.1911972.0211994.642012.9191913.8491959.12
Period201720182019202020212022202320242025TTM
Sales, quarterly511.158502.364458.359468.844492.875493.771476.196487.783501.374
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Shares, annual93.72187.8284.24885.59386.42382.94784.01885.86682.97678.093
Period201720182019202020212022202320242025MRQ
Shares, quarterly85.86685.86685.8186.85485.83382.97682.06181.22378.093
PeriodQ3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue1,959.121,913.852,012.921,994.641,972.021,911.191,733.951,779.763,454.81
Cost of Goods Sold Incl. D&A1,471.211,441.971,590.801,609.251,540.621,430.101,313.071,302.602,619.06
Gross Profit487.92471.88422.12385.39431.40481.10420.88477.16835.75
Selling, General and Administrative Excl. Other249.94240.79238.44227.54231.40263.36248.95244.51403.93
Other Operating Expense0.000.000.000.000.000.000.000.000.00
Operating Income237.98231.09183.68157.85200.00217.74171.93232.65431.82
Interest Expense33.3035.9740.7442.0839.7068.72110.48118.9388.79
Unusual Expense25.3922.27242.69170.5384.3336.6373.8060.890.00
Net Income Before Taxes203.43216.43-101.34-48.3681.37135.237.1558.78355.06
Income Taxes53.3451.04-2.2712.0518.8127.2416.7316.5896.45
Consolidated Net Income150.09165.39-99.07-60.4162.56107.99-9.5842.21258.61
Net Income From Continuing Operations150.09165.39-99.07-60.4162.57108.01-9.5842.21258.61
Net Income150.09165.39-99.07-60.4166.33130.96-796.49-1,497.70268.63
EPS (Recurring)2.112.120.850.721.491.82-8.93-17.432.93
EPS (Basic, Before Extraordinaries)1.881.97-1.19-0.730.791.54-9.55-17.942.95
EPS (Diluted)1.831.94-1.19-0.730.791.53-9.55-17.942.93
EBITDA261.75252.91215.91194.02235.64249.88200.37258.58515.65
Non-Operating Income (Expense)24.1543.58-1.586.395.3922.8419.505.9612.04
Other After Tax Adjustments0.000.000.000.000.000.000.000.000.00
Stock Option Compensation Expense13.736.927.429.2410.7913.2331.4028.2530.58
Price To Earnings Ratio17.2417.24-8.2315.0117.89--11.27
Price To Sales Ratio1.050.950.540.380.631.221.181.300.88
Gross Margin24.9024.6620.9719.3221.8825.1724.2726.8124.19
Operating Margin12.1512.079.137.9110.1411.399.9213.0712.50
Net Margin7.668.64-4.92-3.033.366.85-45.93-84.157.78
Shares Outstanding78.0982.9885.8784.0282.9586.4285.5984.2587.82
Market Capitalization2,470.302,470.301,126.75781.421,234.422,352.372,100.582,342.642,950.86

Income statement, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q22025Q12024Q4
Total Revenue501.37487.78476.20493.77492.88468.84458.36502.36
Cost of Goods Sold Incl. D&A367.35361.10369.35373.42358.08349.43361.05380.71
Gross Profit134.03126.69106.84120.35134.80119.4297.31121.65
Selling, General and Administrative Excl. Other62.7061.2960.2765.6860.7955.7158.6063.55
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income71.3365.4046.5854.6774.0063.7038.7158.10
Interest Expense8.138.178.278.748.949.139.159.71
Unusual Expense6.128.474.925.885.953.836.6120.04
Net Income Before Taxes64.9954.0038.8445.5987.7854.9728.0933.33
Income Taxes18.0014.169.2711.9116.0715.717.352.85
Consolidated Net Income46.9939.8429.5733.6871.7139.2620.7430.48
Net Income From Continuing Operations46.9939.8429.5733.6871.7139.2620.7430.48
Net Income46.9939.8429.5733.6871.7139.2620.7430.48
EPS (Recurring)0.640.560.400.450.890.490.300.52
EPS (Basic, Before Extraordinaries)0.610.500.370.410.850.460.250.35
EPS (Diluted)0.590.490.360.400.840.460.240.35
EBITDA77.5771.1852.7060.3079.5669.0144.0464.97
Non-Operating Income (Expense)7.915.255.455.5428.674.235.144.98
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense4.893.682.812.352.551.511.721.80
Price To Earnings Ratio17.2412.3511.0311.2913.02---
Price To Sales Ratio1.051.060.920.940.750.630.630.56
Gross Margin26.7325.9722.4424.3727.3525.4721.2324.22
Operating Margin14.2313.419.7811.0715.0113.598.4411.57
Net Margin9.378.176.216.8214.558.374.526.07
Shares Outstanding78.0981.2282.0682.9885.8386.8585.8185.87
Market Capitalization2,470.302,080.151,775.391,836.921,458.661,232.751,243.671,126.75

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments499.72348.51177.74103.06487.111,228.71182.3867.4170.49
Short Term Receivables242.31272.60279.88296.79316.02241.93434.27506.72504.00
Inventories0.000.000.000.000.000.000.000.000.00
Other Current Assets21.4818.5025.8328.1437.4378.70114.8685.8452.74
Total Current Assets763.51639.61483.45427.99840.561,549.35731.51659.98627.24
Net Property, Plant & Equipment73.5178.44145.93140.21135.62132.16129.0990.43123.54
Total Investments and Advances0.000.000.000.000.000.000.0069.70100.68
Long-Term Note Receivable20.8028.5033.2054.7058.1061.4029.800.0018.90
Intangible Assets1,277.591,254.201,405.411,550.581,526.991,504.611,508.444,374.604,923.89
Deferred Tax Assets73.92103.86102.85105.9288.3454.4786.6421.91-
Other Assets37.3648.1048.9768.4872.9345.951,690.22720.8673.03
Total Assets2,246.702,152.702,219.812,347.892,722.553,347.954,145.905,937.485,867.28
Short Term Debt Incl. Current Port. of LT Debt38.4033.2535.9936.4922.1721.1518.250.251.40
Accounts Payable37.2246.4334.5931.8636.6559.7735.4131.0634.63
Income Tax Payable0.982.172.1616.2711.070.036.0430.6092.01
Other Current Liabilities382.31352.26316.21342.37357.47363.39482.12440.85403.38
Total Current Liabilities458.91434.11388.95426.98427.37444.33541.82502.76531.42
Long Term Debt596.22629.06665.66680.591,043.651,783.561,774.881,974.281,851.42
Provision for Risks Charges0.000.000.000.000.007.200.000.000.00
Deferred Tax Liabilities57.0234.2534.3133.6441.4161.7556.4795.58159.90
Other Liabilities268.69290.34281.84315.04313.43303.39273.74276.97258.08
Total Liabilities1,380.841,387.761,370.751,456.261,825.852,600.232,646.912,849.602,800.82
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.000.000.000.00
Common Equity865.85764.94849.06891.63896.49747.491,499.003,087.883,066.45
Total Shareholders Equity865.85764.94849.06891.63896.49747.491,499.003,087.883,066.45
Accumulated Minority Interest0.000.000.000.000.200.230.000.000.00
Total Equity865.85764.94849.06891.63896.69747.721,499.003,087.883,066.45
Total Liabilities & Stockholders Equity2,246.702,152.702,219.812,347.892,722.553,347.954,145.905,937.485,867.28
Book Value Per Share10.438.9110.1110.7510.378.7317.7935.1632.72
Tangible Book Value Per Share-4.96-5.70-6.62-7.94-7.30-8.85-0.11-14.65-19.82
Full-Time Employees6,5756,4558,0707,8507,4207,91713,80516,08515,900
Price to Book Ratio2.911.540.811.442.622.811.560.941.71
Return on Assets7.52-4.53-2.652.473.56-0.260.844.385.72
Return on Equity20.28-12.28-6.947.0013.14-0.851.848.4011.00
Return on Invested Capital11.31-7.11-3.994.226.75-31.47-45.755.316.51
Quick Ratio1.661.471.241.001.973.491.351.311.18
Current Ratio1.661.471.241.001.973.491.351.311.18

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income150.09165.39-99.07-60.4166.33130.96-796.49-1,497.70268.63
Depreciation23.7721.8332.2336.1735.6432.1528.4425.9383.83
Other Funds (Non Cash)14.96-10.14187.31169.9555.91-31.77883.651,869.1637.38
Funds from Operations247.26229.26118.33148.95135.11100.10151.89341.68364.19
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital-20.3741.8388.24-11.6331.83-23.3752.7316.03-74.27
Income Taxes Payable-5.50-1.21-5.04-21.6818.23-2.29-6.93-24.12-61.26
Cash from Operating Activities226.88271.09206.57137.32166.9476.74204.62357.71289.93
Capital Expenditures-17.29-18.46-22.02-33.33-29.71-32.25-28.79-19.27-30.48
Net Assets From Acquisitions-11.00-23.20-8.17-6.67-28.17-29.93-2.23-46.98-114.49
Sale of Fixed Assets and Businesses0.000.000.000.000.0024.731.320.0022.76
Purchase or Sale of Investments-23.24-3.18-12.05-8.99-0.46-18.56-28.4116.00-2.17
Purchase of Investments-26.29-29.85-64.55-31.89-17.35-35.05-61.84-35.10-15.88
Sale Or Maturity of Investments3.0526.6752.4922.9116.8916.5033.4351.1013.71
Other Uses0.12-3.460.000.000.000.000.000.00-18.39
Other Sources30.5330.006.830.811.382.93873.86152.690.00
Cash from Investing Activities-20.88-18.30-35.41-48.18-56.95-53.07815.76102.45-142.77
Cash Dividends Paid0.000.000.000.000.000.000.000.000.00
Change in Capital Stock-208.34-83.501.943.99-83.112.13-1.48-134.02-285.90
Repurchase of Common Pref Stock-211.28-86.68-1.70-0.92-88.51-4.72-8.49-145.28-302.16
Sale of Common Pref Stock2.943.183.644.915.406.857.0111.2616.26
Proceedsfrom Stock Options2.943.183.644.915.406.857.0111.2616.26
Issuance or Reduction of Debt, Net-25.20-20.75-15.39-19.12-413.79-762.66-1.67-248.69120.57
Change in Long Term Debt-25.20-20.75-15.39-19.12-413.79-762.66-1.67-248.69120.57
Issuance of Long Term Debt0.000.00235.50470.001,471.380.00526.991,738.112,216.41
Reduction of Long Term Debt-25.20-20.75-250.89-489.12-1,885.17-762.66-528.66-1,986.80-2,095.84
Net Financing Active Other Cash Flow-0.60-3.25-1.03-10.599.350.41-1.25-10.35-5.28
Other Financing Activities Uses-0.60-3.25-1.17-10.590.00-0.19-1.25-10.35-5.28
Cash from Financing Activities-234.14-107.49-14.48-25.71-487.55-760.12-4.40-393.07-170.61
Net Change in Cash-28.14145.30156.6863.43-377.57-736.451,015.9767.10-23.45
Free Cash Flow209.59252.63184.55104.00137.2344.49175.83338.44259.45
Preferred Dividends (Cash Flow)-0.000.000.000.000.000.000.000.00
Price to Free Cash Flow9.797.225.927.359.1152.4911.646.8611.65
Deferred Taxes & Investment Tax Credit-52.19-2.133.24-22.77-31.2436.29-55.72-25.65

Balance sheet, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Cash & Short Term Investments425.84404.20328.97499.72463.10348.33
Short Term Receivables240.29239.00236.99242.31234.94246.62
Inventories0.000.000.000.000.000.00
Other Current Assets17.9516.9421.0721.4819.1618.10
Total Current Assets684.08660.14587.03763.51717.20613.05
Net Property, Plant & Equipment70.9573.8977.9773.5174.3477.63
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets1,281.341,282.761,284.181,277.591,270.221,251.90
Deferred Tax Assets45.1656.1165.7173.9279.7688.73
Other Assets35.2938.5336.2037.3637.6970.78
Total Assets2,139.422,130.342,070.302,246.702,199.412,102.10
Short Term Debt Incl. Current Port. of LT Debt190.97198.42204.3138.4037.5635.73
Accounts Payable25.8927.8531.5437.2238.6542.06
Income Tax Payable1.901.321.400.982.751.95
Other Current Liabilities316.97273.99205.39382.31313.58261.30
Total Current Liabilities535.73501.58442.64458.91392.55341.04
Long Term Debt421.03421.54425.41596.22604.70613.83
Provision for Risks Charges0.000.000.000.000.000.00
Deferred Tax Liabilities61.4358.7157.0057.0238.2836.02
Other Liabilities271.61267.54266.67268.69273.20277.46
Total Liabilities1,289.811,249.371,191.721,380.841,308.741,268.35
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity849.62880.98878.58865.85890.67833.75
Total Shareholders Equity849.62880.98878.58865.85890.67833.75
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity849.62880.98878.58865.85890.67833.75
Total Liabilities & Stockholders Equity2,139.422,130.342,070.302,246.702,199.412,102.10
Book Value Per Share10.8810.8510.7110.4310.389.60
Tangible Book Value Per Share-5.53-4.95-4.94-4.96-4.42-4.81
Full-Time Employees---6,575--
Price to Book Ratio2.912.372.052.061.741.56
Return on Assets6.928.268.577.527.595.37
Return on Equity17.2520.3920.8920.2819.9814.27
Return on Invested Capital3.703.062.272.304.802.71
Quick Ratio1.281.321.331.661.831.80
Current Ratio1.281.321.331.661.831.80

Cash flow, quarterly

Currency USD, millions
Metric2026Q32026Q22026Q12025Q42025Q32025Q2
Net Income46.9939.8429.5733.6871.7139.26
Depreciation6.245.786.125.635.555.31
Other Funds (Non Cash)3.833.483.753.90-18.232.43
Funds from Operations71.1660.5547.7867.7770.1659.11
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital46.1564.78-177.6346.3467.1278.06
Income Taxes Payable3.510.700.87-10.594.612.02
Cash from Operating Activities117.31125.32-129.85114.10137.28137.17
Capital Expenditures-4.38-1.38-6.25-5.29-5.34-4.51
Net Assets From Acquisitions0.000.00-7.00-4.00-19.200.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments-0.267.400.74-31.1231.09-2.69
Purchase of Investments-9.86-3.05-7.01-6.37-1.96-13.77
Sale Or Maturity of Investments9.6010.457.75-24.7533.0411.08
Other Uses0.000.000.000.120.050.05
Other Sources0.000.000.5330.000.000.00
Cash from Investing Activities-4.646.02-11.98-10.286.60-7.15
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.000.000.000.000.00
Change in Capital Stock-82.36-41.67-20.91-63.39-20.170.97
Repurchase of Common Pref Stock-83.04-42.74-21.45-64.04-20.87-0.21
Sale of Common Pref Stock0.681.070.540.650.701.18
Proceedsfrom Stock Options0.681.070.540.650.701.18
Issuance or Reduction of Debt, Net-6.57-6.57-6.73-5.34-5.19-5.19
Change in Long Term Debt-6.57-6.57-6.73-5.34-5.19-5.19
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-6.57-6.57-6.73-5.34-5.19-5.19
Net Financing Active Other Cash Flow-0.700.000.000.10-3.21-0.03
Other Financing Activities Uses-0.700.000.000.10-3.21-0.03
Cash from Financing Activities-89.63-48.24-27.64-68.64-28.56-4.26
Net Change in Cash23.0483.10-169.4635.18115.33125.75
Free Cash Flow112.93123.94-136.09108.81131.95132.65
Price to Free Cash Flow9.799.027.497.155.255.41

Revenue breakdown

Health Care, Patient Service2024: 1.72B 2025: 1.63B
Hospitals Contracts2024: 286.68M 2025: 271.13M
Product and Service, Other2024: 2.63M 2025: 12.21M
United States2024: 2.01B 2025: 1.91B

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-304.61%3.5M76.9M758.59K
2026-10-155.47%4.4M80.0M747.38K
2026-09-305.76%4.6M80.0M771.62K
2026-09-155.91%4.7M80.0M798.24K
2026-08-316.02%4.8M80.0M796.52K
2026-08-146.18%4.9M80.0M798.03K
2026-07-315.18%4.1M80.0M828.03K
2026-07-156.07%4.9M80.8M827.05K
2026-06-304.71%3.8M80.8M791.88K
2026-06-154.66%3.8M80.8M812.48K
2026-05-294.16%3.4M80.8M837.86K
2026-05-154.29%3.5M80.7M939.95K
2026-04-304.22%3.4M80.6M841.72K
2026-04-154.24%3.5M81.6M844.05K
2026-03-314.32%3.5M81.7M819.58K
2026-03-133.72%3.0M81.7M793.81K
2026-02-273.32%2.7M81.7M819.84K
2026-02-133.63%3.0M81.7M790.75K
2026-01-303.31%2.8M84.5M924.40K
2026-01-153.60%3.0M84.5M933.02K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.5026.6029.5020.0316.5350.000.000.997-0.0190.000
call5.0024.4027.0018.9510.4441.000.000.995-0.0200.001
call7.5021.7024.600.009.4600.000.000.994-0.0200.001
call10.0019.4021.8012.847.03213.000.000.992-0.0200.001
call12.5016.9019.3018.405.3521.000.000.984-0.0340.002
call15.0014.4016.808.004.3291.000.000.988-0.0200.002
call17.5011.9014.400.003.4070.000.000.917-0.1360.007
call20.009.8012.5011.403.5889.000.000.981-0.0190.002
call22.506.509.506.202.50810.000.000.975-0.0190.003
call25.004.306.807.101.79228.000.000.829-0.1120.012
call30.000.952.451.971.0611260.000.616-0.0760.018
call35.000.000.300.090.77275.001.000.161-0.0510.012
call40.000.000.750.501.2711.000.000.110-0.0640.009
put2.500.000.050.207.1775.000.00-0.003-0.0170.000
put5.000.000.050.205.1488.000.00-0.005-0.0180.001
put7.500.000.050.054.02727.000.00-0.006-0.0180.001
put10.000.000.050.053.25140.000.00-0.008-0.0180.001
put12.500.002.150.053.0262.000.00-0.016-0.0330.002
put15.000.000.100.232.42813.000.00-0.019-0.0300.002
put17.500.002.150.503.2342.000.00-0.083-0.1340.007
put20.000.000.950.251.40145.000.00-0.019-0.0170.002
put22.500.000.050.932.09816.000.00-0.127-0.1180.010
put25.000.000.950.101.6342.000.00-0.168-0.1100.012
put30.000.550.650.550.53010644.00-0.384-0.0730.018
put35.003.405.203.921.2442.000.00-0.840-0.0480.012
put40.008.4010.300.001.9460.000.00-0.889-0.0600.009

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-10-2910-QQuarterly report pursuant to Section 13 or 15(d)2026-09-30SEC
2026-10-298-KCurrent report2026-10-29SEC
2026-09-14144Filing for proposed sale of securities under Rule 144.SEC
2026-09-14144Filing for proposed sale of securities under Rule 144.SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-09-10144Filing for proposed sale of securities under Rule 144.SEC
2026-09-03SCHEDULE 13GSEC
2026-09-03SCHEDULE 13GSEC
2026-09-03SCHEDULE 13G/ASEC
2026-08-184Statement of changes in beneficial ownership of securities2026-08-14SEC
2026-08-14144Filing for proposed sale of securities under Rule 144.SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-144Statement of changes in beneficial ownership of securities2026-08-12SEC
2026-08-0410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-048-KCurrent report2026-08-04SEC
2026-07-248-KCurrent report2026-07-21SEC
2026-07-158-KCurrent report2026-07-15SEC
2026-07-14SCHEDULE 13GSEC
2026-06-244Statement of changes in beneficial ownership of securities2026-06-22SEC
2026-06-243Initial statement of beneficial ownership of securities2026-06-22SEC
2026-06-104Statement of changes in beneficial ownership of securities2026-06-09SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC
2026-06-034Statement of changes in beneficial ownership of securities2026-06-01SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-0500855.67K1
2026-040000
2026-030000
2026-020000
2026-010000
2025-1200515.43K1
2025-1100457.49K2

Institutional holders

Manager% owned
BlackRock, Inc.16.70%
VANGUARD PORTFOLIO MANAGEMENT LLC7.29%
DIMENSIONAL FUND ADVISORS LP5.42%
VANGUARD CAPITAL MANAGEMENT LLC4.41%
STATE STREET CORP4.30%
VICTORY CAPITAL MANAGEMENT INC3.45%
WASATCH ADVISORS LP2.73%
AMERICAN CENTURY COMPANIES INC2.67%
Allspring Global Investments Holdings, LLC2.55%
GEODE CAPITAL MANAGEMENT, LLC2.54%

Funds

Fund% owned
American Beacon SiM High Yield Opportunities Fund38.18%
iShares Broad USD High Yield Corporate Bond ETF9.03%
State Street(R) SPDR(R) Portfolio High Yield Bond ETF8.84%
iShares Core S&P Small-Cap ETF5.88%
Harbor Core Plus Fund5.87%
Credit Suisse Strategic Income Fund5.61%
Virtus Newfleet Short Duration High Income Fund5.11%
iShares 0-5 Year High Yield Corporate Bond ETF4.34%
Advent Convertible & Income Fund3.72%
Fidelity High Income Fund3.58%

OakChart. MD. Cached 15 minutes.